Colchester Hospital is a district general hospital located in Colchester, Essex. It is managed by East Suffolk and North Essex NHS Foundation Trust.

There are 763 beds in Colchester General Hospital.

During the past decade, Colchester General Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 7 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Colchester General Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "University College, London" with 3 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Colchester General Hospital" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator and "Celgene" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Colchester General Hospital" are "Breast Cancer" (5 trials), "Breast Neoplasms" (3 trials), "Abdominal Aortic Aneurysm" (2 trials), "Diffuse Large B Cell Lymphoma" (2 trials) and "Immune Thrombocytopenic Purpura" (2 trials). Many other conditions were trialed in "Colchester General Hospital" in a lesser frequency.

Most popular intervention types in "Colchester General Hospital" are "Drug" (40 trials), "Biological" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Carboplatin" (5 trials), "Cisplatin" (5 trials), "Cyclophosphamide" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Colchester General Hospital" are 44 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Colchester General Hospital". undefined are not yet recruiting, 11 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Colchester General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Colchester General Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".